Bill > A09252

This bill establishes a comprehensive program to address opioid overdose risks by requiring public access defibrillation providers to store opioid antagonists (such as naloxone nasal spray) alongside automated external defibrillators (AEDs) in various public spaces. The legislation creates a grant program to help providers purchase these opioid antagonists, with a focus on schools, libraries, and community centers in high-risk or underserved areas. The bill mandates that providers maintain and replace the opioid antagonists, track expiration dates, and ensure proper storage. The New York State Department of Health will develop regulations for storage, labeling, and training, and will also provide training resources for administering opioid antagonists. A new dedicated fund will be established to support the grant program, with funding coming from legislative appropriations and other potential sources. The legislative findings emphasize that opioid overdoses are a leading cause of preventable death and that immediate access to opioid antagonists can prevent fatalities. The program is set to take effect on January 1, 2027, with preparatory work authorized immediately.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A9252